TCG Crossover GP I, LLC 13D and 13G filings for Taysha Gene Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 4:24 pm Sale |
2023-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA |
TCG Crossover GP I, LLC | 2,912,861 1.600% |
-8,198,250 (-73.78%) |
Filing |
| 2023-08-25 4:22 pm Purchase |
2023-08-16 | 13G | Taysha Gene Therapies, Inc. TSHA |
TCG Crossover GP I, LLC | 11,111,111 5.900% |
11,111,111 (New Position) |
Filing |